Merck KGaA (OTCMKTS:MKKGY) Shares Gap Up – What’s Next?

by · The Cerbat Gem

Merck KGaA (OTCMKTS:MKKGYGet Free Report)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $27.85, but opened at $28.67. Merck KGaA shares last traded at $28.47, with a volume of 13,789 shares trading hands.

Wall Street Analyst Weigh In

Separately, Barclays downgraded shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 19th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Merck KGaA has a consensus rating of “Hold”.

View Our Latest Analysis on Merck KGaA

Merck KGaA Stock Performance

The stock has a market capitalization of $18.34 billion, a PE ratio of 11.31, a P/E/G ratio of 5.56 and a beta of 0.97. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.97 and a current ratio of 1.49. The firm’s 50 day moving average is $26.79 and its two-hundred day moving average is $26.22.

Merck KGaA (OTCMKTS:MKKGYGet Free Report) last released its earnings results on Thursday, November 13th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.54 by $0.27. Merck KGaA had a return on equity of 10.07% and a net margin of 13.92%.The firm had revenue of $6.17 billion during the quarter, compared to analysts’ expectations of $6.08 billion. As a group, research analysts predict that Merck KGaA will post 1.87 earnings per share for the current year.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading